Tumor size and level of visceral pleura invasion can impact survival of NSCLC...
A study published in the August 2009 edition of the Journal of Thoracic Oncology found that non-small cell lung cancer (NSCLC) patients could be more accurately staged at diagnosis by taking into...
View ArticleNarrow-band imaging increases specificity of early lung cancer detection
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection...
View ArticlePatients' pretreatment quality of life can predict overall lung cancer survival
Research published in the September 2009 issue of the Journal of Thoracic Oncology has found that an individual's quality of life prior to treatment can help predict the overall survival of patients...
View ArticleLung cancer risk increases with expression of specific genes
A recent study published in the October 2009 issue of the Journal of Thoracic Oncology determined that variations of specific genetic markers identified in previous research, or SNPs, may indicate a...
View ArticleCombination of PET/CT tests can expedite diagnosis of lung cancer in a...
Research published in the October 2009 issue of the Journal of Thoracic Oncology has found an effective combination of positron emission tomography (PET)/computed tomography (CT) (PET/CT) tests to...
View ArticleStudy spotlights efficacy of questionnaire to identify patients at high risk...
A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Initiated in 2001,...
View ArticleStudy shows modest improvement in advanced lung cancer overall survival rates
Research released in the December 2009 issue of the Journal of Thoracic Oncology sought to determine whether the survival improvement among patients with metastatic lung cancer has improved over the...
View ArticleResearch confirms efficacy of the newly reclassified TMN staging system
Research released in the January 2010 issue of the Journal of Thoracic Oncology sought to determine and validate the efficacy of the recent reclassification of the T category in the IASLC's Staging...
View ArticleSplit-course palliative radiotherapy confirmed as effective treatment for...
Research published in the February edition of the Journal of Thoracic Oncology sought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients...
View ArticleResearch validates surgery alone offers reasonable overall survival for stage...
Research published in February's edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung...
View ArticlePatient age not a factor in use of second-line therapy for lung cancer
Research published in the March issue of the Journal of Thoracic Oncology sought to determine whether differences existed in tolerance and efficacy between patients age 70 and over and younger patients...
View ArticleStudy shows partial lung removal favorable over full removal as treatment for...
Research published in the April edition of the Journal of Thoracic Oncology sought to compare the outcomes of a sleeve lobectomy and a pneumonectomy procedure, in order to determine which is a more...
View ArticleResearch identifies patterns of CD24, a novel biomarker for non-small cell...
The May edition of the Journal of Thoracic Oncology features a study aimed to clarify expression patterns of a novel cancer biomarker, CD24, in non-small cell lung carcinomas (NSCLC) and to correlate...
View ArticleMicroRNA study provides biomarker for survival in small cell lung cancer
Researchers at the Translational Genomics Research Institute (TGen), the Van Andel Research Institute (VARI) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare have discovered a biomarker...
View ArticleLung cancer research concludes that early diagnosis as key for improving...
Research published in the June edition of the Journal of Thoracic Oncology sought to investigate the time trends of surgical outcomes of patients with non-small cell lung cancer (NSCLC) between 1979...
View ArticleNovel paclitaxel formulation encouraging for treating advanced lung cancer
The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients...
View ArticleNew method of tissue banking makes gene analysis more practical for lung cancer
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a...
View ArticleResearch defines timeframes, factors to deem early stage lung cancer cured
In patients with non-small cell lung cancer (NSCLC), five-year disease-free survival is currently the benchmark of cure. However, there are two issues that remain with the follow-up standards: (1) When...
View ArticleLung cancer survivors experience long-term effects of breathlessness
With the growing number of long-term lung cancer survivors, research is needed to identify and address cancer survivorship issues. One of the most common and debilitating symptoms among lung cancer...
View ArticleLung cancer survival rates improved through use of individualized chemotherapy
Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at...
View Article
